Cargando…
Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
Multiple myeloma (MM) is characterised by destructive lytic bone disease, caused by induction of bone resorption and impaired bone formation. Our understanding of the molecular mechanisms responsible for osteoblast suppression, are limited. Using the 5T2MM murine model of MM we have previously shown...
Autores principales: | Faraahi, Z., Baud'huin, M., Croucher, P.I., Eaton, C., Lawson, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458996/ https://www.ncbi.nlm.nih.gov/pubmed/30776499 http://dx.doi.org/10.1016/j.bone.2019.02.012 |
Ejemplares similares
-
Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92]
por: Faraahi, Z., et al.
Publicado: (2019) -
BMP3 expression by osteoblast lineage cells is regulated by canonical Wnt signaling
por: Kokabu, Shoichiro, et al.
Publicado: (2017) -
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas
por: Jacques, Camille, et al.
Publicado: (2020) -
Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST
por: Gipson, Gregory R., et al.
Publicado: (2020) -
Role of Sostdc1 in skeletal biology and cancer
por: Tong, Xiaoyang, et al.
Publicado: (2022)